Strom Carrie C's Form 4 filing
AbbVie Inc. (ABBV) · filed Aug 25, 2021
- Accession no.
- 0001179110-21-008422
- Filed
- Aug 25, 2021
- Trade date
- Aug 23, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $606.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strom Carrie CCIK 0001811896 | Officer (SVP & Pres Global Allerg Aesth) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2021 | Common Stock, $0.01 par value | SSaleDisposed | −5,057 | $120.00 | −$606,840 | 51,047 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The transaction reported on this Form 4 was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).